首页 | 本学科首页   官方微博 | 高级检索  
     

过氧化物酶体增殖物激活受体α在结直肠癌发病机制中的作用
引用本文:魏仁杰,杨烈,章烈,卢铀,胡建昆,莫显明,周总光. 过氧化物酶体增殖物激活受体α在结直肠癌发病机制中的作用[J]. 普外基础与临床杂志, 2013, 0(11): 1320-1324
作者姓名:魏仁杰  杨烈  章烈  卢铀  胡建昆  莫显明  周总光
作者单位:[1]四川大学华西医院胃肠外科中心,四川成都610041 [2]四川大学华西医院肿瘤科,四川成都610041 [3]四川大学华西医院生物治疗国家重点实验室医学干细胞生物学中心,四川成都610041
摘    要:
目的探讨过氧化物酶体增殖物激活受体α(PPARα)在结直肠癌发病机制中的作用。方法对PPARα与结直肠癌的发病机制相关研究的文献进行综述。结果PPARα在结直肠癌发病机制中对结直肠癌细胞增殖、凋亡、分化的作用仍存在争议。结论PPARα有可能参与了结直肠癌细胞增殖、分化、凋亡等的调控过程,但其具体作用机制以及其上、下游的信号通路仍不清楚。此外,PPARα可能参与了结直肠癌部分化疔药物的耐药机制,但其作用也不甚明了。因此,需要更多的研究工作来进一步探究PPARα与结直肠癌的关系:

关 键 词:过氧化物酶体增殖物活化受体α  结直肠癌  发病机制

Role of Peroxisome Proliferator Activated Receptor a in Pathogenesis of Colorectal Cancer
WEI Ren-jie,YANG Lie,ZHANG Lie,LU You,HU Jian-kun,MO Xian-ming,ZHOU Zong-guang. Role of Peroxisome Proliferator Activated Receptor a in Pathogenesis of Colorectal Cancer[J]. , 2013, 0(11): 1320-1324
Authors:WEI Ren-jie  YANG Lie  ZHANG Lie  LU You  HU Jian-kun  MO Xian-ming  ZHOU Zong-guang
Affiliation:1. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, Siehuan Province, China; 2. Department of Oncology, West China Hospital, Siehuan University, Chengdu 610041, Sichuan Province, China; 3. Laboratory of Stem Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China Corresponding Author : ZHOU Zong-guang, E-mail: zhou767@163, com)
Abstract:
Objective To investigate the role of peroxisome proliferator activated receptor α (PPARα) in the pathogenesis of colorectal cancer. Method The literatures about PPARα and the pathogenesis of colorectal cancer were reviewed and analyzed. Result The relationships of PPARα to the proliferation, apoptosis, and differentiation of colorectal cancer cells in the pathogenesis of colorectal cancer were controversial. Conclusions PPARα might be involved in the regulation of proliferation, differentiation, apoptosis of colorectal cancer cells, but the pathogenesis and the up- and down-stream signal pathways are not elucidated. In additional, PPARα might partly be involved in the mechanism of drug resistance of chemotherapy drugs for coloreetal cancer, but the role is not very clear yet. So more research works need to be done about the relationship of PPARα to pathogenesis of colorectal cancer.
Keywords:Peroxisome proliferator activated receptor ct  Colorectal cancer  Pathogenesis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号